Haploidentical Kir ligand-mismatched Natural Killer Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Haploidentical Kir ligand-mismatched Natural Killer Cells, covering 2009-09-24 to 2009-09-24. Get the full timeline:
Most recent: Clinical Trial Update: Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-mismatched Natural Killer Cells [Phase 1]